why choose us

First received: January 19, 2023

Clinical Trial: VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Psoriatic Arthritis

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Patients With Active Psoriatic Arthritis

Brief Summary: The objective of this study is to evaluate if VTX958 is safe and effective in adult participants with active Psoriatic Arthritis.Approximately 195 eligible participants will take VTX958 Dose A, VTX958 Dose B, or matching placebo (no active drug) for 16 weeks and then move on to a 36 week Long Term Extension (LTE).The study will include 16 weeks of treatment, 36 weeks of LTE, and a 30-day follow-up period.

Read more